Clinical Trial Update: A Research Study of a New Medicine NNC0363-1063 in Healthy Participants and Participants With Type 1 Diabetes [Phase 1]

View source ↗

Summary

This document provides an update on a Phase 1 clinical trial of the new medicine NNC0363-1063 in healthy participants and participants with Type 1 diabetes. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• NNC0363-1063

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED